Skip to main content
Top
Published in: Child's Nervous System 12/2019

01-12-2019 | Intellectual Disability | Case Report

Non-convulsive status epilepticus in two patients with tuberous sclerosis

Authors: Yuksel Erdal, Alper Alnak, Ozgur Oztop, Pınar Tekturk, Zuhal Yapici

Published in: Child's Nervous System | Issue 12/2019

Login to get access

Abstract

Tuberous sclerosis (TSC) is an autosomal dominantly inherited genetic disorder that chiefly affects the central nervous system, along with the other multiple systems. While phenomenology and symptom severity may vary greatly from one individual to another, the most common neurological presentation is epilepsy, which may be refractory in a considerable number of patients. Convulsive SE is seen frequently in TSC patients due to the high ratio of refractory seizures in well-studied cohorts. Status epilepticus (SE) is a life-threating condition and requires urgent medical care. Non-convulsive status epilepticus (NCSE) is an epileptic state with no convulsive seizures but impaired consciousness and corresponding electrophysiological findings. Due to its heterogeneity of clinical features, it is generally hard to recognize, and thus difficult to treat promptly. The relationship between TSC and NCSE is a relatively less emphasized issue in the literature. Here, we present two cases of TSC with NCSE with a view to increasing clinicians’ awareness of the association between refractory epilepsy and NCSE.
Literature
1.
go back to reference Akman CI (2010) Nonconvulsive status epilepticus and continuous spike and slow wave of sleep in children. Semin Pediatr Neurol 17(3):155–162CrossRef Akman CI (2010) Nonconvulsive status epilepticus and continuous spike and slow wave of sleep in children. Semin Pediatr Neurol 17(3):155–162CrossRef
2.
go back to reference Almaabdi KH, Alshehri RO, Althubiti AA et al (2014) Intravenous methylprednisolone for intractable childhood epilepsy. Pediatr Neurol 50:334–336CrossRef Almaabdi KH, Alshehri RO, Althubiti AA et al (2014) Intravenous methylprednisolone for intractable childhood epilepsy. Pediatr Neurol 50:334–336CrossRef
3.
go back to reference Chu-shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA (2011) The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51(7):1236–1241CrossRef Chu-shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA (2011) The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51(7):1236–1241CrossRef
4.
go back to reference Crino PB (2016) The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol 12(7):379–392CrossRef Crino PB (2016) The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol 12(7):379–392CrossRef
5.
go back to reference Curatolo P, Jóźwiak S, Nabbout R (2012) Management of epilepsy associated with tuberous sclerosis complex ( TSC ): clinical recommendations. Eur J Paediatr Neurol 16(6):582–586CrossRef Curatolo P, Jóźwiak S, Nabbout R (2012) Management of epilepsy associated with tuberous sclerosis complex ( TSC ): clinical recommendations. Eur J Paediatr Neurol 16(6):582–586CrossRef
6.
go back to reference Curatolo P, Moavero R, De Vries PJ (2015) Neurological and neuropsychiatric aspects of tuberous. Lancet Neurol 14(7):733–745CrossRef Curatolo P, Moavero R, De Vries PJ (2015) Neurological and neuropsychiatric aspects of tuberous. Lancet Neurol 14(7):733–745CrossRef
7.
go back to reference Curatolo P, Nabbout R, Lagae L et al (2018) Management of epilepsy associated with tuberous sclerosis complex: updated clinical recommendations. Eur J Paediatr Neurol 22(5):738–748CrossRef Curatolo P, Nabbout R, Lagae L et al (2018) Management of epilepsy associated with tuberous sclerosis complex: updated clinical recommendations. Eur J Paediatr Neurol 22(5):738–748CrossRef
8.
go back to reference French JA, Lawson JA, Yapici Z et al (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis ( EXIST-3 ): a phase 3, randomised , double-blind , placebo-controlled study. Lancet 6736(16):1–11 French JA, Lawson JA, Yapici Z et al (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis ( EXIST-3 ): a phase 3, randomised , double-blind , placebo-controlled study. Lancet 6736(16):1–11
9.
go back to reference Jafarpour S, Stredny CM, Piantino J, Chapman KE (2018) Baseline and outcome assessment in pediatric status epilepticus. Seizure 68:52–61CrossRef Jafarpour S, Stredny CM, Piantino J, Chapman KE (2018) Baseline and outcome assessment in pediatric status epilepticus. Seizure 68:52–61CrossRef
10.
go back to reference Kuki I, Kawawaki H, Okazaki S, Ehara E, Yoshida Y, Kunihiro N, Matsusaka Y (2018) Efficacy and safety of everolimus in patients younger than 12 months with congenital subependymal giant cell astrocytoma. Brain and Development 40(5):415–420CrossRef Kuki I, Kawawaki H, Okazaki S, Ehara E, Yoshida Y, Kunihiro N, Matsusaka Y (2018) Efficacy and safety of everolimus in patients younger than 12 months with congenital subependymal giant cell astrocytoma. Brain and Development 40(5):415–420CrossRef
11.
go back to reference Maganti R, Gerber P, Drees C, Chung S (2008) Nonconvulsive status epilepticus. Epilepsy Behav 12:572–586CrossRef Maganti R, Gerber P, Drees C, Chung S (2008) Nonconvulsive status epilepticus. Epilepsy Behav 12:572–586CrossRef
12.
go back to reference Pera MC, Randazzo G, Masnada S et al (2015) Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy. Funct Neurol 30(3):173–179PubMedPubMedCentral Pera MC, Randazzo G, Masnada S et al (2015) Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy. Funct Neurol 30(3):173–179PubMedPubMedCentral
13.
go back to reference Savini MN, Mingarelli A, Vignoli A et al (2018) Ictal signs in tuberous sclerosis complex : Clinical and video-EEG features in a large series of recorded seizures. Epilepsy Behav 85:14–20CrossRef Savini MN, Mingarelli A, Vignoli A et al (2018) Ictal signs in tuberous sclerosis complex : Clinical and video-EEG features in a large series of recorded seizures. Epilepsy Behav 85:14–20CrossRef
14.
go back to reference Schubert-bast S, Rosenow F, Martin K, Reif PS, Kieslich M, Strzelczyk A (2018) The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: current evidence and future perspectives. Epilepsy Behav 91:94–98CrossRef Schubert-bast S, Rosenow F, Martin K, Reif PS, Kieslich M, Strzelczyk A (2018) The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: current evidence and future perspectives. Epilepsy Behav 91:94–98CrossRef
15.
go back to reference Shehata HS, Abdel Ghaffar HM, Nasreldin M, Elmazny A, Abdelalim A, Sabbah A, Shalaby NM (2017) Clinical patterns and outcomes of status epilepticus in patients with tuberous sclerosis complex. Ther Clin Risk Manag 13:779–785CrossRef Shehata HS, Abdel Ghaffar HM, Nasreldin M, Elmazny A, Abdelalim A, Sabbah A, Shalaby NM (2017) Clinical patterns and outcomes of status epilepticus in patients with tuberous sclerosis complex. Ther Clin Risk Manag 13:779–785CrossRef
16.
go back to reference Trinka E, Cock H, Hesdorffer D et al (2015) A definition and classification of status epilepticus–report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56(10):1515–1523CrossRef Trinka E, Cock H, Hesdorffer D et al (2015) A definition and classification of status epilepticus–report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56(10):1515–1523CrossRef
Metadata
Title
Non-convulsive status epilepticus in two patients with tuberous sclerosis
Authors
Yuksel Erdal
Alper Alnak
Ozgur Oztop
Pınar Tekturk
Zuhal Yapici
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 12/2019
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-019-04382-y

Other articles of this Issue 12/2019

Child's Nervous System 12/2019 Go to the issue